- Home
- NKTX vs BANX Comparison
NKTX vs BANX Comparison
Compare NKTX & BANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTX
- BANX
- Stock Information
- Founded
- NKTX 2015
- BANX 2013
- Country
- NKTX United States
- BANX United States
- Employees
- NKTX N/A
- BANX N/A
- Industry
- NKTX Biotechnology: Pharmaceutical Preparations
- BANX Trusts Except Educational Religious and Charitable
- Sector
- NKTX Health Care
- BANX Finance
- Exchange
- NKTX Nasdaq
- BANX Nasdaq
- Market Cap
- NKTX 123.5M
- BANX 146.9M
- IPO Year
- NKTX 2020
- BANX N/A
- Fundamental
- Price
- NKTX $1.97
- BANX $22.17
- Analyst Decision
- NKTX Strong Buy
- BANX
- Analyst Count
- NKTX 5
- BANX 0
- Target Price
- NKTX $13.50
- BANX N/A
- AVG Volume (30 Days)
- NKTX 519.8K
- BANX 23.4K
- Earning Date
- NKTX 11-06-2025
- BANX 06-17-2025
- Dividend Yield
- NKTX N/A
- BANX 9.66%
- EPS Growth
- NKTX N/A
- BANX N/A
- EPS
- NKTX N/A
- BANX 2.35
- Revenue
- NKTX N/A
- BANX $29,467,794.00
- Revenue This Year
- NKTX N/A
- BANX N/A
- Revenue Next Year
- NKTX N/A
- BANX N/A
- P/E Ratio
- NKTX N/A
- BANX $8.88
- Revenue Growth
- NKTX N/A
- BANX 2.73
- 52 Week Low
- NKTX $1.31
- BANX $17.99
- 52 Week High
- NKTX $5.88
- BANX $21.67
- Technical
- Relative Strength Index (RSI)
- NKTX 49.97
- BANX 78.50
- Support Level
- NKTX N/A
- BANX $21.17
- Resistance Level
- NKTX $2.08
- BANX $21.35
- Average True Range (ATR)
- NKTX 0.10
- BANX 0.25
- MACD
- NKTX -0.10
- BANX 0.12
- Stochastic Oscillator
- NKTX 85.43
- BANX 97.09
About NKTX Nkarta Inc.
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.
About BANX ArrowMark Financial Corp.
ArrowMark Financial Corp is a non-diversified, closed-end management investment company. Its objective is to provide stockholders with current income, and to a lesser extent capital appreciation. The company's investments in various portfolios such as debt securities, Trust Preferred and Preferred Securities, preferred securities, exchange-traded funds, money market funds and others.